Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chalazion × Triamcinolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pain 1 Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leiomyoma 1 Keratosis, Actinic 1 Hodgkin Disease 1 Dermatitis, Contact 1 Dendritic Cell Sarcoma, Interdigitating 1 Chalazion 1 Carcinoma, Basal Cell 1 Burkitt Lymphoma 1 Anemia, Refractory, with Excess of Blasts 1 Adenomyosis 1

Interventions

Conservative Treatment 3 Probiotics 2 Curettage 2 Triamcinolone Acetonide 1 Triamcinolone 1 Tetracycline 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡